Global Heart Defect Closure Devices Market Insights, Forecast to 2025

Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.
The classification of Heart Defect Closure Devices includes ASD Closure Devices, VSD Closure Devices, PDA Closure Devices, PFO Closure Devices and LAA Closure Devices. And the proportion of Amplatzer PFO Occluder in 2017 is about 33%, and the proportion is in decreasing trend from 2013 to 2017. LAA Closure Devices with the growth rate about 18%, in 2017 the market share is nearly 22%.
Heart Defect Closure Devices is widely used in hospitals and clinics. The most proportion of Heart Defect Closure Devices is used in Hospital, and the proportion in 2017 is 61%. Europe is the largest consumption place, with a consumption market share nearly 30% in 2017. Following Europe, North America is the second largest consumption place with the consumption market share of 27%.
Market competition is not intense. Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates and Starway are the leaders of the industry, with high-end customers.
The global Heart Defect Closure Devices market is valued at 649.1 million US$ in 2018 and will reach 1186.7 million US$ by the end of 2025, growing at a CAGR of 9.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Heart Defect Closure Devices market based on company, product type, end user and key regions.

This report studies the global market size of Heart Defect Closure Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Heart Defect Closure Devices in these regions.
This research report categorizes the global Heart Defect Closure Devices market by top players/brands, region, type and end user. This report also studies the global Heart Defect Closure Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore and Associates
Starway
Coherex Medical
Cardia
MicroPort

Heart Defect Closure Devices market size by Type
ASD Closure Devices
VSD Closure Devices
PDA Closure Devices
PFO Closure Devices
LAA Closure Devices
Heart Defect Closure Devices market size by Applications
Hospitals
Clinics

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Heart Defect Closure Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Heart Defect Closure Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Heart Defect Closure Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Heart Defect Closure Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Heart Defect Closure Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Heart Defect Closure Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.